The Claim
Creatine monohydrate augmentation of escitalopram in women with major depressive disorder increases prefrontal N-acetylaspartate levels after 8 weeks of treatment.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In women with major depressive disorder, taking creatine monohydrate along with escitalopram for 8 weeks results in higher levels of N-acetylaspartate in the prefrontal brain region.
See the scientific wording
Creatine monohydrate augmentation of escitalopram in women with major depressive disorder leads to increased prefrontal N-acetylaspartate levels after 8 weeks, suggesting a potential effect on brain energy metabolism.
Creatine enters brain cells and gets converted into a molecule that stores energy. When brain cells need more energy, this stored energy is used to make ATP, the main fuel for cells. With more ATP available, neurons can produce more N-acetylaspartate, a chemical that reflects healthy neuron function. This extra energy also helps repair and strengthen the wiring between brain regions, especially in areas that control mood and thinking.
What the research says
1 studyWomen with depression who took creatine along with their antidepressant had more of a brain chemical linked to energy production than those who took a placebo. This suggests creatine may help the brain use energy better, which could explain why they felt better.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.